Marshall Wace North America’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-55,372	Closed	-$1.75M	–	1604
2021 Q1	$1.75M	Buy	+55,372	New	+$2.3M	0.01%	862
2020 Q4	–	Sell	-44,724	Closed	-$1.47M	–	1431
2020 Q3	$1.47M	Sell	44,724 -289,448	-87%	-$8.87M	0.01%	688
2020 Q2	$9.17M	Buy	334,172 +247,369	+285%	+$8.13M	0.06%	278
2020 Q1	$2.6M	Buy	86,803 +77,955	+881%	+$2.07M	0.02%	438
2019 Q4	$245K	Buy	+8,848	New	+$201K	﹤0.01%	929
2019 Q3	–	Sell	-210,174	Closed	-$5.15M	–	1408
2019 Q2	$5.15M	Sell	210,174 -105,275	-33%	-$1.59M	0.03%	356
2019 Q1	$3M	Buy	315,449 +247,321	+363%	+$2.4M	0.02%	415
2018 Q4	$603K	Sell	68,128 -145,054	-68%	-$1.4M	0.01%	735
2018 Q3	$2.4M	Sell	213,182 -324,486	-60%	-$4.61M	0.02%	455
2018 Q2	$6.88M	Sell	537,668 -1,141,303	-68%	-$16.7M	0.04%	433
2018 Q1	$28.4M	Buy	+1,678,971	New	+$25.4M	0.14%	163
2017 Q3	–	Sell	-13,191	Closed	-$92K	–	1386
2017 Q2	$92K	Buy	+13,191	New	+$83.9K	﹤0.01%	1255